←Back to Expert Scholars
Translational Medicine / 转化医学Chemotherapy Induced Peripheral Neuropathy
Charles L. Loprinzi
MD
🏢Mayo Clinic🌐USA
Emeritus Professor of Oncology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dr. Charles Loprinzi is a pioneer in cancer symptom management research and led the CALGB 170601 trial that established duloxetine for painful chemotherapy induced peripheral neuropathy. He has contributed to international ASCO guidelines for CIPN. His program defined modern supportive care standards in oncology.
Share:
🧪Research Fields 研究领域
CIPN
duloxetine
supportive care
clinical trials
cancer symptom management
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Charles L. Loprinzi 的研究动态
Follow Charles L. Loprinzi's research updates
留下邮箱，当我们发布与 Charles L. Loprinzi（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment